Market Intelligence & Analysis

Gold continues to be supported by structural demand from central banks and persistent macroeconomic uncertainty. While short-term price movements remain sensitive to real interest rates and US dollar dynamics, the broader demand backdrop remains materially stronger than in prior cycles. Silver and other industrial metals remain more exposed to cyclical recovery trends, particularly in energy transition-related demand.

Healthcare transaction activity remains selective rather than broad-based. Strategic buyers continue to lead activity, while financial sponsors maintain disciplined underwriting standards. Financing conditions, valuation alignment, and regulatory clarity remain key determinants of transaction execution across both developed and emerging markets.

Regulatory execution remains a central challenge for medical device companies, particularly under EU MDR. Notified body capacity constraints and increasing documentation requirements continue to affect certification timelines. In the US, FDA review processes remain highly dependent on submission quality and device classification, reinforcing the importance of early-stage regulatory planning.